+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Biomarker Diagnostic Kits Market by Biomarker Type (B-Type Natriuretic Peptide, C-Reactive Protein, Cardiac Troponin), Indication (Angina Pectoris, Heart Failure, Myocardial Infarction), Testing Type, Purchasing Mode, Application, End User - Global Forecast 2025-2030- Product Image
Cardiac Biomarker Diagnostic Kits Market by Biomarker Type (B-Type Natriuretic Peptide, C-Reactive Protein, Cardiac Troponin), Indication (Angina Pectoris, Heart Failure, Myocardial Infarction), Testing Type, Purchasing Mode, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Cardiac Biomarker Diagnostic Kits Market by Biomarker Type (B-Type Natriuretic Peptide, C-Reactive Protein, Cardiac Troponin), Indication (Angina Pectoris, Heart Failure, Myocardial Infarction), Testing Type, Purchasing Mode, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011196
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cardiac biomarker diagnostic kits market is evolving rapidly, driven by the increasing need for objective, early detection and personalized management of cardiovascular conditions. Senior executives require a holistic view of emerging technologies, regulatory shifts, and regional trends to inform strategic investments and sustain competitive advantage.

Market Snapshot: Cardiac Biomarker Diagnostic Kits

The Cardiac Biomarker Diagnostic Kits Market grew from USD 3.22 billion in 2024 to USD 3.45 billion in 2025. It is expected to continue growing at a CAGR of 7.22%, reaching USD 4.90 billion by 2030. This steady expansion reflects the market’s response to demand for high-sensitivity biomarkers and increasing adoption across diverse clinical and research environments. Advances in laboratory automation, point-of-care solutions, and digital health integration drive accessible, real-time decision support for cardiac care. Strategic collaborations between diagnostics manufacturers and healthcare providers are further supporting the transition toward personalized medicine and improved patient outcomes.

Scope & Segmentation

  • Biomarker Types: B-Type Natriuretic Peptide, C-Reactive Protein, Cardiac Troponin, Creatine Kinase-MB, Myoglobin.
  • Indications: Angina Pectoris, Heart Failure, Myocardial Infarction.
  • Testing Types: In Vitro Testing, In Vivo Testing.
  • Purchasing Modes: Direct Purchasing, Third-Party Suppliers.
  • Applications: Laboratory Testing (Central Laboratory, Point-of-Care), Research Applications.
  • End Users: Academic & Research Institutions, Diagnostic Laboratories, Hospitals & Clinics.
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe Middle East & Africa (including United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asia markets).
  • Key Companies: Abbott Laboratories, Atlas Medical GmbH, Beckman Coulter, Bio-Rad Laboratories, bioMérieux SA, Creative Diagnostics, Eurolyser Diagnostica, F. Hoffmann-La Roche, Fujirebio Diagnostics, GenWay Biotech, Guangzhou Wondfo Biotech, J.Mitra & Co., Lepu Medical Technology, Medtronic, Meridian Bioscience, MP Biomedicals, Radiometer Medical, Randox Laboratories, Siemens Healthcare, Singulex, SSI Diagnostica A/S Group, Thermo Fisher Scientific, Tosoh Corporation, Trivitron Healthcare, Tulip Diagnostics.

Key Takeaways for Senior Decision-Makers

  • Early and precise cardiac care is increasingly supported by diagnostic kits that combine novel molecular targets with automated and point-of-care technologies.
  • Advancements in immunoassays and microfluidics enable integration into both centralized labs and emergency or outpatient environments, supporting faster, more actionable clinical decisions.
  • Artificial intelligence and machine learning enhance value by enabling more sophisticated risk stratification and predictive modeling, opening new opportunities for digital health innovation.
  • Growth in the Asia-Pacific region is projected to outpace other areas, underpinned by rising cardiovascular disease incidence and governmental investment in healthcare infrastructure.
  • Strategic partnerships and targeted acquisitions are driving market consolidation, expanding geographic reach and enriching product portfolios with next-generation diagnostic solutions.
  • Ongoing regulatory evolution and evolving reimbursement frameworks are incentivizing both innovation and operational adaptability across the cardiac biomarker diagnostics ecosystem.

Tariff Impact on the Cardiac Biomarker Diagnostic Kits Market

Newly implemented tariffs in the United States from 2025 are expected to reshape supply chain planning and cost structures for manufacturers that depend on imported assay components and reagents. Companies are proactively seeking supply partner diversification and exploring domestic or regional production hubs to mitigate risk. These strategies aim to enhance supply chain resilience and maintain price stability amid geopolitical shifts, while incentivizing further investments in proprietary technologies and preferred supplier agreements.

Methodology & Data Sources

This market study draws from primary data through interviews with key stakeholders and structured surveys of laboratory directors, clinicians, and procurement managers. Extensive secondary research, including regulatory filings and peer-reviewed literature, complemented and validated the strategic findings. Analytical frameworks included competitor benchmarking, SWOT analysis, and scenario modeling for high confidence in market insights.

Why This Report Matters

  • Enables C-suite executives and strategy teams to anticipate disruptive market shifts and align R&D investments accordingly.
  • Delivers actionable segment and regional intelligence for optimized commercial strategies and resource allocation.

Conclusion

The cardiac biomarker diagnostic kits market is characterized by accelerating innovation, evolving business models, and adaptive regulatory landscapes. Informed, agile strategies are essential for organizations seeking sustainable growth and clinical impact across this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multiplexed point-of-care assays for simultaneous troponin and natriuretic peptide detection in emergency settings
5.2. Adoption of high-sensitivity cardiac troponin assays to reduce time to diagnosis and improve patient outcomes in acute coronary syndrome
5.3. Development of microfluidic lab-on-a-chip platforms enabling rapid cardiac biomarker quantification at bedside
5.4. Expansion of next-generation sequencing-based biomarkers for personalized risk stratification in heart failure management
5.5. Emergence of artificial intelligence algorithms for predictive interpretation of multimarker cardiac panels in clinical workflow
5.6. Growth of non-invasive saliva and urine-based assays for monitoring cardiac biomarker levels in outpatient care
5.7. Strategic partnerships between diagnostic companies and academic centers to validate novel cardiac marker panels in clinical trials
5.8. Regulatory approval of combination immunoassays for simultaneous detection of inflammatory and myocardial injury markers in acute care
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiac Biomarker Diagnostic Kits Market, by Biomarker Type
8.1. Introduction
8.2. B-Type Natriuretic Peptide
8.3. C-Reactive Protein
8.4. Cardiac Troponin
8.5. Creatine Kinase-MB
8.6. Myoglobin
9. Cardiac Biomarker Diagnostic Kits Market, by Indication
9.1. Introduction
9.2. Angina Pectoris
9.3. Heart Failure
9.4. Myocardial Infarction
10. Cardiac Biomarker Diagnostic Kits Market, by Testing Type
10.1. Introduction
10.2. In Vitro Testing
10.3. In Vivo Testing
11. Cardiac Biomarker Diagnostic Kits Market, by Purchasing Mode
11.1. Introduction
11.2. Direct Purchasing
11.3. Third-Party Suppliers
12. Cardiac Biomarker Diagnostic Kits Market, by Application
12.1. Introduction
12.2. Laboratory Testing
12.2.1. Central Laboratory Testing
12.2.2. Point-of-Care Testing
12.3. Research Applications
13. Cardiac Biomarker Diagnostic Kits Market, by End User
13.1. Introduction
13.2. Academic & Research Institutions
13.3. Diagnostic Laboratories
13.4. Hospitals & Clinics
14. Americas Cardiac Biomarker Diagnostic Kits Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cardiac Biomarker Diagnostic Kits Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cardiac Biomarker Diagnostic Kits Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Atlas Medical GmbH
17.3.3. Beckman Coulter, Inc.
17.3.4. Bio-Rad Laboratories, Inc.
17.3.5. bioMérieux SA
17.3.6. Creative Diagnostics
17.3.7. Eurolyser Diagnostica GmbH
17.3.8. F. Hoffmann-La Roche Ltd.
17.3.9. Fujirebio Diagnostics, Inc.
17.3.10. GenWay Biotech, Inc.
17.3.11. Guangzhou Wondfo Biotech Co., Ltd.
17.3.12. J.Mitra & Co. Pvt. Ltd.
17.3.13. Lepu Medical Technology (Beijing) Co., Ltd.
17.3.14. Medtronic Inc.
17.3.15. Meridian Bioscience, Inc.
17.3.16. MP Biomedicals, LLC
17.3.17. Radiometer Medical ApS
17.3.18. Randox Laboratories Ltd.
17.3.19. Siemens Healthcare GmbH
17.3.20. Singulex, Inc.
17.3.21. SSI Diagnostica A/S Group
17.3.22. Thermo Fisher Scientific, Inc.
17.3.23. Tosoh Corporation
17.3.24. Trivitron Healthcare
17.3.25. Tulip Diagnostics (P) Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: RESEARCHAI
FIGURE 28. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: RESEARCHSTATISTICS
FIGURE 29. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: RESEARCHCONTACTS
FIGURE 30. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC TROPONIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC TROPONIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CREATINE KINASE-MB, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CREATINE KINASE-MB, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY IN VITRO TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY IN VITRO TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY IN VIVO TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY IN VIVO TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIRECT PURCHASING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIRECT PURCHASING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY THIRD-PARTY SUPPLIERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY THIRD-PARTY SUPPLIERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CENTRAL LABORATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CENTRAL LABORATORY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 96. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 97. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 98. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 99. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 100. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 101. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 104. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 105. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 118. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 119. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 184. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 185. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 190. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 191. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 198. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 199. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 204. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 205. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 222. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 223. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 224. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 225. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 226. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 227. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 228. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 229. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 232. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 233. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 238. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 239. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 240. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 241. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 246. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 247. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PURCHASING MODE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 292. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 293. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. DENMARK CARDIAC BIOMARKER DIAGNOSTI

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Atlas Medical GmbH
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Creative Diagnostics
  • Eurolyser Diagnostica GmbH
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio Diagnostics, Inc.
  • GenWay Biotech, Inc.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • J.Mitra & Co. Pvt. Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Inc.
  • Meridian Bioscience, Inc.
  • MP Biomedicals, LLC
  • Radiometer Medical ApS
  • Randox Laboratories Ltd.
  • Siemens Healthcare GmbH
  • Singulex, Inc.
  • SSI Diagnostica A/S Group
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Trivitron Healthcare
  • Tulip Diagnostics (P) Ltd

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.9 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cardiac Biomarker Diagnostic Test Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Cardiac Biomarker Diagnostic Test Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 209 Pages
  • Global
From
Cardiac Biomarkers Market Report 2025 - Product Image

Cardiac Biomarkers Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cardiac Biomarkers Market Report and Forecast 2024-2032 - Product Image

Cardiac Biomarkers Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Cardiac Biomarker Market by Biomarker Type (BNP & NT-proBNP, Creatine Kinase (CK) MB, Myoglobin), Clinical Setting (Laboratory Testing, Point Of Care Testing), Application, End User - Global Forecast 2025-2030 - Product Image

Cardiac Biomarker Market by Biomarker Type (BNP & NT-proBNP, Creatine Kinase (CK) MB, Myoglobin), Clinical Setting (Laboratory Testing, Point Of Care Testing), Application, End User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Global Cardiac Biomarkers Diagnostics Industry, 2024-2029 - Product Image

Global Cardiac Biomarkers Diagnostics Industry, 2024-2029

  • Report
  • Global
From

About the Cardiac Marker Testing Market

The Cardiac Marker Testing market is a subset of the Laboratory Testing market, which focuses on the diagnosis and monitoring of cardiac diseases. Cardiac markers are proteins or enzymes released into the bloodstream in response to cardiac injury or stress. These markers can be used to diagnose and monitor a variety of cardiac conditions, such as myocardial infarction, congestive heart failure, and arrhythmias. Cardiac marker testing is typically performed using immunoassay techniques, such as ELISA, CLIA, and chemiluminescence. Cardiac marker testing is an important tool for the diagnosis and management of cardiac diseases, and is used in both clinical and research settings. It is also used to monitor the effectiveness of treatments and to assess the risk of future cardiac events. Companies in the Cardiac Marker Testing market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.